Scientists and Physicians to Collaborate on Cancer Care at Annual Symposium in Albany

President of the American Association for Cancer Research is Keynote Speaker

ALBANY, N.Y., Sept. 26, 2014 — A unique forum will bring together scientists who study cancer and physicians who treat cancer patients with the goal of sharing information to improve care options. The 8th Annual Translational Oncology Research Symposium takes place Thursday andFriday, Oct. 16-17, at the Hilton Garden Inn Albany Medical Center.

Hosted by Albany Medical College and New York Oncology Hematology, P.C. (NYOH), the event is jointly sponsored by the Medical College of Wisconsin. The 2014 symposium will focus on breast and lung cancers, as well as tumors of unknown primary origin.

Friday morning’s keynote address will be delivered by Carlos Arteaga, M.D., president of the American Association for Cancer Research, and a leading breast cancer researcher. He will discuss his research related to molecular markers in breast cancer progression.

Thursday evening’s keynote speaker is Vincent Miller, M.D., of Foundation Medicine, Cambridge, Mass., who will discuss lung cancer and genetic sequencing.

Vincent Verdile, M.D., dean of Albany Medical College and executive vice president for health affairs at Albany Medical Center, and Karen Tedesco, M.D., medical oncologist/hematologist and director of the NYOH Hereditary Cancer Risk Assessment Program, will moderate the symposium, which features a series of panel presentations.

“Each year, we offer this unique opportunity to bring together leading physicians and scientists to discuss applying innovative research findings to patient care initiatives, which we all hope will lead to better outcomes for our patients,” said Dr. Verdile.

The symposium is co-chaired by Dr. Tedesco and Paul Higgins, Ph.D., and Paula McKeown-Longo, Ph.D., co-directors of Albany Med’s Center for Cell Biology and Cancer Research.

“Through laboratory based, translational, and clinical research collaboration between NYOH and Albany Medical Center, we continue to offer our patients personalized and innovative cancer treatments which lead to improved outcomes,” said Dr. Tedesco. “Together, we are providing patients with state-of the-art care – close to home.”

For more information or to register, visit www.TransOncNY.org.